Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade

Immune checkpoint blocking antibodies are currently being tested in ovarian cancer (OC) patients and have shown some responses in early clinical trials. However, it remains unclear how human OC cancer cells regulate lymphocyte activation in response to therapy. In this study, we have established and...

Descripción completa

Detalles Bibliográficos
Autores principales: Natoli, Marina, Bonito, Nair, Robinson, James D., Ghaem-Maghami, Sadaf, Mao, Yumeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347689/
https://www.ncbi.nlm.nih.gov/pubmed/32200422
http://dx.doi.org/10.1007/s00262-020-02544-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347689/
https://www.ncbi.nlm.nih.gov/pubmed/32200422
http://dx.doi.org/10.1007/s00262-020-02544-5

Ejemplares similares